Impact of 15-deoxyspergualin on effector cells in experimental autoimmune diseases of the nervous system in the Lewis rat.

Por Jung, S, Toyka, K V, Hartung, H P
Publicado em 1994

Modulation of the expression of integrins on glial cells during experimental autoimmune encephalomyelitis. A central role for TNF-alpha.

Por Previtali, S. C., Archelos, J. J., Hartung, H. P.
Publicado em 1997

T-cell receptor (TCR) usage in Lewis rat experimental autoimmune encephalomyelitis: TCR beta-chain-variable-region V beta 8.2-positive T cells are not essential for induction and c...

Por Gold, R, Giegerich, G, Hartung, H P, Toyka, K V
Publicado em 1995

Release of prostaglandin E and thromboxane from macrophages by stimulation with factor H.

Por Hartung, H P, Hadding, U, Bitter-Suermann, D, Gemsa, D
Publicado em 1984

Clinical applications of intravenous immunoglobulins (IVIg) – beyond immunodeficiencies and neurology

Por Hartung, H-P, Mouthon, L, Ahmed, R, Jordan, S, Laupland, K B, Jolles, S
Publicado em 2009

Bacteria and their cell wall components uniformly co-activate interleukin-17-producing thymocytes

Por Weber, A, Zimmermann, C, Kieseier, B C, Hartung, H-P, Hofstetter, H H
Publicado no Clin Exp Immunol (2014)

Therapeutic effect of transforming growth factor-beta 2 on actively induced EAN but not adoptive transfer EAN.

Por Jung, S, Schluesener, H J, Schmidt, B, Fontana, A, Toyka, K V, Hartung, H P
Publicado em 1994

Macrophages in T cell line-mediated, demyelinating, and chronic relapsing experimental autoimmune encephalomyelitis in Lewis rats.

Por Huitinga, I, Ruuls, S R, Jung, S, Van Rooijen, N, Hartung, H P, Dijkstra, C D
Publicado em 1995

Transforming growth factor-beta 1 in experimental autoimmune neuritis. Cellular localization and time course.

Por Kiefer, R., Funa, K., Schweitzer, T., Jung, S., Bourde, O., Toyka, K. V., Hartung, H. P.
Publicado em 1996

Free caspase activity in CSF of patients with dementia

Por Albrecht, P., Schmitz, M., Otto, M., Hemmer, B., Zerr, I., Hartung, H.-P., Methner, Axel
Publicado em 2009

Relation of clinical, serological, morphological, and electrophysiological findings in galactocerebroside-induced experimental allergic neuritis.

Por Stoll, G, Schwendemann, G, Heininger, K, Köhne, W, Hartung, H P, Seitz, R, Toyka, K V
Publicado em 1986

Localization of interferon-gamma and Ia-antigen in T cell line-mediated experimental autoimmune encephalomyelitis.

Por Stoll, G., Müller, S., Schmidt, B., van der Meide, P., Jung, S., Toyka, K. V., Hartung, H. P.
Publicado em 1993

T cell activation status determines the cytokine pattern induced by zymosan and bacterial DNA both in thymocytes and splenocytes

Por Zimmermann, C, Weber, A, Mausberg, A K, Kieseier, B C, Hartung, H P, Hofstetter, H H
Publicado em 2013

Requirement for safety monitoring for approved multiple sclerosis therapies: an overview

Por Rommer, P S, Zettl, U K, Kieseier, B, Hartung, H-P, Menge, T, Frohman, E, Greenberg, B M, Hemmer, B, Stüve, O
Publicado em 2014

Recommendations for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS)

Por Langdon, DW, Amato, MP, Boringa, J, Brochet, B, Foley, F, Fredrikson, S, Hämäläinen, P, Hartung, H-P, Krupp, L, Penner, IK, Reder, AT, Benedict, RHB
Publicado em 2012

A Case of Relapsing-Remitting Neuroborreliosis? Challenges in the Differential Diagnosis of Recurrent Myelitis

Por Albrecht, P., Henke, N., Lehmann, H.C., Macht, S., Hefter, H., Goebels, N., Mackenzie, C., Rupprecht, T.A., Fingerle, V., Hartung, H.P., Methner, A.
Publicado em 2012

Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation

Por Ingwersen, J., Wingerath, B., Graf, J., Lepka, K., Hofrichter, M., Schröter, F., Wedekind, F., Bauer, A., Schrader, J., Hartung, H.-P., Prozorovski, T., Aktas, O.
Publicado no J Neuroinflammation (2016)

Long-term impact of interferon beta-1b in patients with CIS: 8-year follow-up of BENEFIT

Por Edan, G, Kappos, L, Montalbán, X, Polman, C H, Freedman, M S, Hartung, H-P, Miller, D, Barkhof, F, Herrmann, J, Lanius, V, Stemper, B, Pohl, C, Sandbrink, R, Pleimes, D
Publicado em 2014

Predictive nature of IgM anti-α-glucose serum biomarker for relapse activity and EDSS progression in CIS patients: a BENEFIT study analysis

Por Freedman, MS, Metzig, C, Kappos, L, Polman, CH, Edan, G, Hartung, H-P, Miller, DH, Montalban, X, Yarden, J, Spector, L, Fire, E, Dotan, N, Schwenke, S, Lanius, V, Sandbrink, R, Pohl, C
Publicado em 2012

Interferon β-1b and glatiramer acetate effects on permanent black hole evolution

Por Filippi, M., Rocca, M.A., Camesasca, F., Cook, S., O'Connor, P., Arnason, B.G.W., Kappos, L., Goodin, D., Jeffery, D., Hartung, H.-P., Comi, G., Wolinsky, J.S., Bogumil, T., Pohl, C., Beckmann, K., Sandbrink, R., Croze, E., Brown, C., DeSimone, T.M., Arnold, D.L., Cutter, G., Knappertz, V.
Publicado em 2011